BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30983016)

  • 1. Striking contiguous depigmentation across the lower limbs in piebaldism and its implications for understanding melanocytic migration and development.
    Funkhouser CH; Kinsler VA; Frieden IJ
    Pediatr Dermatol; 2019 Jul; 36(4):511-513. PubMed ID: 30983016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piebaldism in a 3-month-old infant--case report.
    Milankov O; Savić R; Radulović A
    Med Pregl; 2014; 67(3-4):109-10. PubMed ID: 24961053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Piebaldism: a pigmentary anomaly to recognize: about a case and review of the literature].
    El Kouarty H; Dakhama BS
    Pan Afr Med J; 2016; 25():155. PubMed ID: 28292117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piebaldism in a 2-year-old girl.
    López V; Jordá E
    Dermatol Online J; 2011 Feb; 17(2):13. PubMed ID: 21382296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIT-related piebaldism in a Chinese girl.
    Zhu L; Yang C; Zhong W; Huang YQ; Zhang Q; Xu WC; Chen YF
    Am J Med Genet A; 2020 Jun; 182(6):1321-1328. PubMed ID: 32220041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of human melanocyte development, Piebaldism, and Waardenburg syndrome.
    Saleem MD
    Pediatr Dermatol; 2019 Jan; 36(1):72-84. PubMed ID: 30561083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice transgenic for Kit(V620A): recapitulation of piebaldism but not progressive depigmentation seen in humans with this mutation.
    Tosaki H; Kunisada T; Motohashi T; Aoki H; Yoshida H; Kitajima Y
    J Invest Dermatol; 2006 May; 126(5):1111-8. PubMed ID: 16456533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piebaldism: an autonomous autosomal dominant entity.
    Winship I; Young K; Martell R; Ramesar R; Curtis D; Beighton P
    Clin Genet; 1991 May; 39(5):330-7. PubMed ID: 1860249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piebaldism in children.
    Grob A; Grekin S
    Cutis; 2016 Feb; 97(2):90-2. PubMed ID: 26919497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Holmes SA; Itin P; Küster W
    J Invest Dermatol; 1993 Jul; 101(1):22-5. PubMed ID: 7687267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel KIT mutation results in piebaldism with progressive depigmentation.
    Richards KA; Fukai K; Oiso N; Paller AS
    J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piebaldism, Waardenburg syndrome, and related disorders of melanocyte development.
    Spritz RA
    Semin Cutan Med Surg; 1997 Mar; 16(1):15-23. PubMed ID: 9125761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piebaldism.
    Oiso N; Fukai K; Kawada A; Suzuki T
    J Dermatol; 2013 May; 40(5):330-5. PubMed ID: 22670867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striking contiguous depigmentation across the lower limbs in piebaldism, its implications for understanding melanocytic migration, development.
    Pediatr Dermatol; 2020 May; 37(3):585. PubMed ID: 32598540
    [No Abstract]   [Full Text] [Related]  

  • 15. [Piebaldisme: a rare genodermatosis].
    Debbarh FZ; Mernissi FZ
    Pan Afr Med J; 2017; 27():221. PubMed ID: 28979623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes.
    Dessinioti C; Stratigos AJ; Rigopoulos D; Katsambas AD
    Exp Dermatol; 2009 Sep; 18(9):741-9. PubMed ID: 19555431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel splicing mutation of KIT results in piebaldism and auburn hair color in a Chinese family.
    Yang YJ; Zhao R; He XY; Li LP; Wang KW; Zhao L; Tu M; Tang JS; Xie ZG; Zhu YM
    Biomed Res Int; 2013; 2013():689756. PubMed ID: 24000325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Griscelli syndrome type 3-like phenotype with MYO-5A exon-F deletion.
    Yılmaz M; Çağdaş D; Grandin V; Altıntaş DU; Tezcan İ; de Saint Basile G; Sanal Ö
    Pediatr Allergy Immunol; 2014 Dec; 25(8):817-9. PubMed ID: 25283056
    [No Abstract]   [Full Text] [Related]  

  • 19. Human piebaldism: relationship between phenotype and site of kit gene mutation.
    Ward KA; Moss C; Sanders DS
    Br J Dermatol; 1995 Jun; 132(6):929-35. PubMed ID: 7544995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the SLUG (SNAI2) gene results in human piebaldism.
    Sánchez-Martín M; Pérez-Losada J; Rodríguez-García A; González-Sánchez B; Korf BR; Kuster W; Moss C; Spritz RA; Sánchez-García I
    Am J Med Genet A; 2003 Oct; 122A(2):125-32. PubMed ID: 12955764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.